Peripheral Blood Inflammation Profile of Patients with Pulmonary Arterial Hypertension Using the High-Throughput Olink Proteomics Platform.
作者信息
Mickael Claudia, Kheyfets Vitaly O, Langouët-Astrié Christophe, Lee Michael H, Sanders Linda A, Trentin Caio O, Sweatt Andrew J, Zamanian Roham T, Bull Todd M, Stenmark Kurt, Graham Brian B, Tuder Rubin M
机构信息
University of Colorado Denver Aurora, Colorado.
University of California, San Francisco San Francisco, California.
出版信息
Am J Respir Cell Mol Biol. 2022 May;66(5):580-581. doi: 10.1165/rcmb.2021-0369LE.
Abstract
摘要
相似文献
1
Peripheral Blood Inflammation Profile of Patients with Pulmonary Arterial Hypertension Using the High-Throughput Olink Proteomics Platform.
Am J Respir Cell Mol Biol. 2022 May;66(5):580-581. doi: 10.1165/rcmb.2021-0369LE.
2
Prime Time for Proteomics in Pulmonary Arterial Hypertension Risk Assessment?
Am J Respir Crit Care Med. 2022 May 1;205(9):988-990. doi: 10.1164/rccm.202201-0040ED.
3
Decoding the Link Between Inflammation and Pulmonary Arterial Hypertension.
Circulation. 2022 Sep 27;146(13):1023-1025. doi: 10.1161/CIRCULATIONAHA.122.059949. Epub 2022 Sep 26.
4
Determining the Architecture of Inflammation in Pulmonary Arterial Hypertension.
Am J Respir Crit Care Med. 2024 Jan 15;209(2):131-133. doi: 10.1164/rccm.202310-1987ED.
5
The Pathobiology of Pulmonary Arterial Hypertension.
Cardiol Clin. 2022 Feb;40(1):1-12. doi: 10.1016/j.ccl.2021.08.001.
6
Checkpoint Kinase 1 Promotes the Development of Pulmonary Arterial Hypertension.
Arterioscler Thromb Vasc Biol. 2019 Aug;39(8):1504-1506. doi: 10.1161/ATVBAHA.119.312969. Epub 2019 Jul 24.
7
Targeted proteomics of right heart adaptation to pulmonary arterial hypertension.
Eur Respir J. 2021 Apr 8;57(4). doi: 10.1183/13993003.02428-2020. Print 2021 Apr.
8
Immune Cells in Pulmonary Arterial Hypertension.
Heart Lung Circ. 2022 Jul;31(7):934-943. doi: 10.1016/j.hlc.2022.02.007. Epub 2022 Mar 28.
9
Circulating markers of inflammation and angiogenesis and clinical outcomes across subtypes of pulmonary arterial hypertension.
J Heart Lung Transplant. 2023 Feb;42(2):173-182. doi: 10.1016/j.healun.2022.10.026. Epub 2022 Nov 7.
10
Endogenous Retroviral Elements Generate Pathologic Neutrophils in Pulmonary Arterial Hypertension.
Am J Respir Crit Care Med. 2022 Oct 15;206(8):1019-1034. doi: 10.1164/rccm.202102-0446OC.
引用本文的文献
1
Serum Olink Targeted Proteomics Identifies IL-17A as a Prospective Inflammatory Marker for the Prediction and Diagnosis of Kawasaki Disease.
J Inflamm Res. 2025 Mar 4;18:3093-3103. doi: 10.2147/JIR.S506154. eCollection 2025.
2
Nbeal2 knockout mice are not protected against hypoxia-induced pulmonary vascular remodeling and pulmonary hypertension.
Blood Adv. 2025 Apr 8;9(7):1571-1584. doi: 10.1182/bloodadvances.2024013880.
3
Prognostic Significance of Proteomics-Discovered Circulating Inflammatory Biomarkers in Patients With Pulmonary Arterial Hypertension.
J Am Heart Assoc. 2024 Jun 18;13(12):e032888. doi: 10.1161/JAHA.123.032888. Epub 2024 Jun 14.
4
Dexamethasone prophylaxis protects from acute high-altitude illness by modifying the peripheral blood mononuclear cell inflammatory transcriptome.
Biosci Rep. 2023 Nov 30;43(11). doi: 10.1042/BSR20231561.
本文引用的文献
1
The deubiquitinase STAMBP modulates cytokine secretion through the NLRP3 inflammasome.
Cell Signal. 2021 Mar;79:109859. doi: 10.1016/j.cellsig.2020.109859. Epub 2020 Nov 27.
2
Discovery of Distinct Immune Phenotypes Using Machine Learning in Pulmonary Arterial Hypertension.
Circ Res. 2019 Mar 15;124(6):904-919. doi: 10.1161/CIRCRESAHA.118.313911.
3
Circulating miRNAs in Pediatric Pulmonary Hypertension Show Promise as Biomarkers of Vascular Function.
Oxid Med Cell Longev. 2017;2017:4957147. doi: 10.1155/2017/4957147. Epub 2017 Jul 27.
4
TGF-β activation by bone marrow-derived thrombospondin-1 causes Schistosoma- and hypoxia-induced pulmonary hypertension.
Nat Commun. 2017 May 30;8:15494. doi: 10.1038/ncomms15494.
5
Pulmonary vascular remodeling in pulmonary hypertension.
Cell Tissue Res. 2017 Mar;367(3):643-649. doi: 10.1007/s00441-016-2539-y. Epub 2016 Dec 26.
6
Novel signaling pathways in pulmonary arterial hypertension (2015 Grover Conference Series).
Pulm Circ. 2016 Sep;6(3):285-94. doi: 10.1086/688034.
7
Eukaryotic initiation factor 4E-binding protein 1 (4E-BP1): a master regulator of mRNA translation involved in tumorigenesis.
Oncogene. 2016 Sep 8;35(36):4675-88. doi: 10.1038/onc.2015.515. Epub 2016 Feb 1.
8
The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes.
Am J Physiol Lung Cell Mol Physiol. 2015 Feb 1;308(3):L229-52. doi: 10.1152/ajplung.00238.2014. Epub 2014 Nov 21.
9
Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension.
Circ Res. 2014 Jun 20;115(1):165-75. doi: 10.1161/CIRCRESAHA.113.301141.
10
Modern age pathology of pulmonary arterial hypertension.
Am J Respir Crit Care Med. 2012 Aug 1;186(3):261-72. doi: 10.1164/rccm.201201-0164OC. Epub 2012 Jun 7.
Zotero 插件